Your session is about to expire
← Back to Search
Diagnostic Monitoring Techniques for Light Sensitivity
N/A
Recruiting
Research Sponsored by Randy Kardon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18-80
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial will test a new way of diagnosing and treating light sensitivity and headache by measuring a person's facial features, pupil responses, retinal electrical responses, and autonomic nerve responses to light.
Who is the study for?
This trial is for healthy individuals aged 18-80 who have had a normal eye exam in the past year. It's designed to help those with traumatic brain injury and associated light sensitivity or migraines by objectively measuring their response to light.Check my eligibility
What is being tested?
The study tests new methods like videography, ocular coherence tomography (OCT), wrist-watch sensor devices, pupillography, and electrophysiology to diagnose and monitor treatment of light sensitivity and headaches in patients.See study design
What are the potential side effects?
Since this trial involves diagnostic tools rather than medications, traditional side effects are not expected. However, participants may experience discomfort from bright lights or wearing sensors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 80 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlation of facial responses to light sensitivity
Difference in objective biological markers of light sensitivity between light sensitive and normal subjects
Secondary outcome measures
Correlation of objective biological marker of light sensitivity to macula (structure found in the back of the eye).
Correlation of objective biological marker of light sensitivity to optic nerve structures
Trial Design
5Treatment groups
Active Control
Group I: TBI patients with photosensitivityActive Control5 Interventions
Group II: Migraine patients with photosensitivityActive Control5 Interventions
Group III: Migraine patients without photosensitivityActive Control5 Interventions
Group IV: TBI Patients without photosensitivityActive Control5 Interventions
Group V: Healthy Control subjectsActive Control5 Interventions
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for light sensitivity often involve the use of diagnostic tools that measure facial features, pupil responses, retinal electrical responses, and autonomic nerve responses to light. These tools help in objectively assessing the physiological reactions to light exposure, which is essential for accurate diagnosis and effective treatment planning.
By understanding these mechanisms, healthcare providers can develop personalized treatment strategies that address the specific triggers and symptoms of light sensitivity, ultimately improving patient outcomes and quality of life.
Treatment of vitiligo with 308-nm light emitting diode: Our experience from a two-year follow-up of Chinese patients.Aspects of Diode Laser (805 nm) Hair Removal Safety in a Mixed-Race Group of Patients.[The physical and chemical properties of the skin and the action of therapeutic physical factors].
Treatment of vitiligo with 308-nm light emitting diode: Our experience from a two-year follow-up of Chinese patients.Aspects of Diode Laser (805 nm) Hair Removal Safety in a Mixed-Race Group of Patients.[The physical and chemical properties of the skin and the action of therapeutic physical factors].
Find a Location
Who is running the clinical trial?
Randy KardonLead Sponsor
3 Previous Clinical Trials
1,001 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 80 years old.
Research Study Groups:
This trial has the following groups:- Group 1: TBI patients with photosensitivity
- Group 2: Migraine patients with photosensitivity
- Group 3: Migraine patients without photosensitivity
- Group 4: TBI Patients without photosensitivity
- Group 5: Healthy Control subjects
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger